Baudax Bioinc Stock In The News

BXRX Stock  USD 0.01  0.0003  2.91%   
The tone or emotional content of news articles related to Baudax BioInc can affect its prices. Positive news sentiment can lead to an increase in demand for Baudax BioInc's stock, while negative news sentiment can lead to a decrease in demand. Our overall analysis of Baudax BioInc's news coverage and content from conventional and social sources shows investors' indifference towards Baudax BioInc. The specific impact of Baudax BioInc news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Baudax BioInc's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Baudax BioInc headlines in addition to utilizing other, more conventional financial analysis modules. Check out Baudax BioInc Backtesting and Baudax BioInc Hype Analysis.
For more information on how to buy Baudax Stock please use our How to Invest in Baudax BioInc guide.

Baudax BioInc Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Baudax Bio Announces Corporate Update
https://www.globenewswire.com/news-release/2023/10/18/2762296/0/en/Baudax-Bio-Announces-Corporate-Update.html
 Bullish
Macroaxis News: globenewswire.com
Baudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168 for the Treatment of Hemophilia A with Inhibitors
https://www.globenewswire.com/news-release/2023/09/28/2751180/0/en/Baudax-Bio-Announces-Orphan-Drug-Designation-Granted-by-U-S-FDA-for-TI-168-for-the-Treatment-of-Hemophilia-A-with-Inhibitors.html
 Bullish
Macroaxis News: globenewswire.com
Baudax Bio to Participate in the H.C. Wainwright Global Investment Conference
https://www.globenewswire.com/news-release/2023/09/07/2739292/0/en/Baudax-Bio-to-Participate-in-the-H-C-Wainwright-Global-Investment-Conference.html
 Neutral
Macroaxis News: globenewswire.com
Baudax Bio Announces Distribution of Series C Preferred Stock to Holders of its Common Stock
https://www.globenewswire.com/news-release/2023/08/23/2730353/0/en/Baudax-Bio-Announces-Distribution-of-Series-C-Preferred-Stock-to-Holders-of-its-Common-Stock.html
 Bullish
Macroaxis News: globenewswire.com
Baudax Bio Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
https://www.globenewswire.com/news-release/2023/08/17/2727199/0/en/Baudax-Bio-Announces-1-9-Million-Registered-Direct-Offering-Priced-At-The-Market-under-Nasdaq-Rules.html
 Bullish
Macroaxis News: globenewswire.com
Baudax Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
https://www.globenewswire.com/news-release/2023/08/16/2726283/0/en/Baudax-Bio-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Business-Update.html
 Bullish
Macroaxis News: globenewswire.com
Baudax Bio Acquires TeraImmune, Inc.
https://www.globenewswire.com/news-release/2023/06/30/2697710/0/en/Baudax-Bio-Acquires-TeraImmune-Inc.html
 Bullish
Macroaxis News: globenewswire.com
Baudax Bio Announces Additional, Positive Top-Line Results From Phase 2 Randomized Clinical Trial of BX1000
https://www.globenewswire.com/news-release/2023/06/07/2683858/0/en/Baudax-Bio-Announces-Additional-Positive-Top-Line-Results-From-Phase-2-Randomized-Clinical-Trial-of-BX1000.html
 Bullish
Macroaxis News: globenewswire.com
Baudax Bio Announces Date of Reconvened Annual Meeting
https://www.globenewswire.com/news-release/2023/06/06/2682905/0/en/Baudax-Bio-Announces-Date-of-Reconvened-Annual-Meeting.html
 Neutral
Macroaxis News: globenewswire.com
Baudax Bio Reports First Quarter Financial Results and Provides Business Update
https://www.globenewswire.com/news-release/2023/05/12/2667813/0/en/Baudax-Bio-Reports-First-Quarter-Financial-Results-and-Provides-Business-Update.html
 Bullish

Baudax BioInc Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Baudax and other traded companies coverage. We help investors stay connected with Baudax headlines for the 30th of April to make an informed investment decision based on correlating the impacts of news items on Baudax Stock performance. Please note that trading solely based on the Baudax BioInc hype is not for everyone as timely availability and quick action are needed to avoid losses.
Baudax BioInc's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Baudax BioInc investors visualize upcoming and past events in order to time the market based on Baudax BioInc noise-free hype analysis.
Baudax BioInc stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Baudax earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Baudax BioInc that are available to investors today. That information is available publicly through Baudax media outlets and privately through word of mouth or via Baudax internal channels. However, regardless of the origin, that massive amount of Baudax data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Baudax BioInc news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Baudax BioInc relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Baudax BioInc's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Baudax BioInc alpha.

Baudax Largest EPS Surprises

Earnings surprises can significantly impact Baudax BioInc's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-09-30
2023-09-30-0.53-0.30.2343 
2023-08-16
2023-06-30-2.04-1.520.5225 
2019-11-12
2019-09-30-1.14-1.84-0.761 
2023-02-23
2022-12-31-9.76-12.33-2.5726 
2022-11-08
2022-09-30-21.2-26.4-5.224 
2022-08-11
2022-06-30-50.8-42.08.817 
View All Earnings Estimates

Baudax BioInc Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Baudax BioInc Stock. Current markets are slightly bullish. About 53% of major world exchanges and indexes are currently up. See today's market update for more information.
Macroaxis News
5th of April 2024
Disposition of tradable shares by Kim Yong Chan of Baudax BioInc subject to Rule 16b-3
at MacroaxisInsider 
Macroaxis News
11th of March 2024
Insider Trading
at MacroaxisInsider 
news
20th of February 2024
Baudax Bio to Release Quarterly Earnings on Wednesday
at thelincolnianonline.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Baudax BioInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Baudax BioInc's short interest history, or implied volatility extrapolated from Baudax BioInc options trading.
When determining whether Baudax BioInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Baudax BioInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Baudax Bioinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Baudax Bioinc Stock:
Check out Baudax BioInc Backtesting and Baudax BioInc Hype Analysis.
For more information on how to buy Baudax Stock please use our How to Invest in Baudax BioInc guide.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for Baudax Stock analysis

When running Baudax BioInc's price analysis, check to measure Baudax BioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Baudax BioInc is operating at the current time. Most of Baudax BioInc's value examination focuses on studying past and present price action to predict the probability of Baudax BioInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Baudax BioInc's price. Additionally, you may evaluate how the addition of Baudax BioInc to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Global Correlations
Find global opportunities by holding instruments from different markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Is Baudax BioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Baudax BioInc. If investors know Baudax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Baudax BioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(94.13)
Revenue Per Share
0.318
Quarterly Revenue Growth
(0.23)
Return On Assets
(1.15)
Return On Equity
(47.04)
The market value of Baudax BioInc is measured differently than its book value, which is the value of Baudax that is recorded on the company's balance sheet. Investors also form their own opinion of Baudax BioInc's value that differs from its market value or its book value, called intrinsic value, which is Baudax BioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Baudax BioInc's market value can be influenced by many factors that don't directly affect Baudax BioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Baudax BioInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baudax BioInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baudax BioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.